Thyroid Cancer Cells Grow Less in Lab than Normal Cells
Author Information
Author(s): T.P. Dawson, F.S. Wyllie, D. Wynford-Thomas
Primary Institution: University of Wales College of Medicine
Hypothesis
Is there an inverse relationship between in vitro growth response to serum growth factors and in vivo malignancy in human thyroid epithelial cells?
Conclusion
Thyroid cancer cells show a significantly reduced proliferative response to serum growth factors compared to normal thyroid cells.
Supporting Evidence
- Normal thyroid cultures showed a maximum 3H-thymidine labelling index of around 50%.
- Three out of four adenomas demonstrated a much reduced or delayed response to serum.
- In carcinomas, labelling was never more than 5% and in one case was undetectable.
Takeaway
When scientists looked at thyroid cells from cancer patients, they found that these cells didn't grow as well in the lab compared to normal thyroid cells.
Methodology
The study involved comparing the DNA synthesis response of primary thyroid epithelial cultures from normal, benign, and malignant tissues to serum and a defined serum substitute.
Limitations
The study had a small sample size and limited analysis of carcinoma cases due to the rarity of samples.
Participant Demographics
The study included thyroid tissue samples from both male and female patients aged 13 to 70.
Want to read the original?
Access the complete publication on the publisher's website